Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$103.53 USD
-1.56 (-1.48%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $103.53 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $4.71 | 0.00% |
Earnings Summary
For their last quarter, Jazz Pharmaceuticals (JAZZ) reported earnings of $2.68 per share, missing the Zacks Consensus Estimate of $4.14 per share. This reflects a negative earnings surprise of 35.27%. Look out for JAZZ's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of $4.71 per share, reflecting a year-over-year increase of 4.43%.
Earnings History
Price & Consensus
Zacks News for JAZZ
JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services